AI Analysis AI Analysis of XGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XGN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Exagen Inc. stock price took a fall of -6.97% on Monday
(Updated on Jul 13, 2026)

Hold candidate since Jul 13, 2026

The Exagen Inc. stock price fell by -6.97% on the last day (Monday, 13th Jul 2026) from $4.45 to $4.14. During the last trading day the stock fluctuated 7.52% from a day low at $4.12 to a day high of $4.43. The price has fallen in 6 of the last 10 days and is down by -9.61% for this period. Volume has increased on the last day by 187 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 281 thousand shares were bought and sold for approximately $1.16 million.

Given the current short-term trend, the stock is expected to rise 51.05% during the next 3 months and, with a 90% probability hold a price between $6.25 and $9.57 at the end of this 3-month period.

XGN Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Exagen Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.47 and $4.56. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -22.62%. Further fall is indicated until a new bottom pivot has been found. Exagen Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Exagen Inc. stock

Exagen Inc. finds support from accumulated volume at $3.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.310 between high and low, or 7.52%. For the last week, the stock has had daily average volatility of 8.19%.

Our recommended stop-loss: $3.93 (-5.10%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 28 days ago.)

Trading Expectations (XGN) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Exagen Inc. to open at $4.23, and during the day (based on 14 day Average True Range), to move between $3.97 and $4.31, which gives a possible trading interval of +/-$0.339 (+/-8.53%) up or down from last closing price. If Exagen Inc. takes out the full calculated possible swing range there will be an estimated 8.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.98 (3.86%) than the resistance at $4.36 (5.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Exagen Inc. stock A Buy?

Exagen Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.753 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $4.23 ( 2.17%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XGN Performance

Trading levels for XGN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.54 9.66%
R2 4.42 6.80%
R1 4.35 5.03%
Price 4.14
S1 4.11 -0.686%
S2 4.04 -2.45%
S3 3.92 -5.31%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.01 21.01%
R2 4.54 9.66%
R1 4.36 5.31%
Price 4.14
S1 3.98 -3.86%
S2 3.73 -9.90%
S3 3.71 -10.39%

FAQ

What is the symbol for Exagen Inc. Stock and on which exchange is it traded?
The symbol for Exagen Inc. is XGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Exagen Inc. Stock?
Exagen Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Exagen Inc. Stock?
Exagen Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Exagen Inc. Stock.

What's the current price of Exagen Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an Exagen Inc. (XGN) share was $4.14.

What is the 52-week high and low for Exagen Inc. Stock?
The 52-week high for Exagen Inc. Stock is $12.23 and the 52-week low is $2.61.

What is the market capitalization of Exagen Inc. Stock?
As of the Jul 13, 2026, the market capitalization of Exagen Inc. is 100.022M.

When is the next earnings date for Exagen Inc.?
The upcoming earnings date for Exagen Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT EXAGEN INC.
Exagen
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables diff...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE